Form4insider filings, from the source

SEC Form 4 · accession 0001652252-16-000093

BIO-RAD LABORATORIES, INC. · BIO BIO.B

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
Sep 7, 2016
Accepted (ET)
Sep 9, 2016 · 3:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Bio-Rad A Common Stockholding———411,252D
Bio-Rad B Common Stockholding———197,763D
Bio-Rad B Common StockF1holding———12,586IBy Spouse
Bio-Rad B Common StockF2holding———4,060,054IBy Blue Raven Partners, L.P.
Bio-Rad B Common StockF3holding———13,726IBy DANSA Partnership

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5$0.00Sep 7, 2016A15,000A——Bio-Rad B Common Stock15,00015,000D
Non-Qualified Stock Option (right to buy)F6$159.32Sep 7, 2016A15,000A—Sep 7, 2026Bio-Rad B Common Stock15,00015,000D

Explanation of responses